NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE69795 Query DataSets for GSE69795
Status Public on Aug 18, 2015
Title a phase 2 trial of DDMVAC and bevacizumab in urothelial cancer
Organism Homo sapiens
Experiment type Expression profiling by array
Summary A prognostic gene expression signature in chemotherapy-naïve bladder cancer is predictive of clinical outcomes from neoadjuvant chemotherapy
 
Overall design 61 FFPE bladder tumors were used to validate chemo-resistant subtype in bladder cancer
 
Contributor(s) Choi W, Lee I, Siefker-Radtke A, McConkey D
Citation(s) 26343003
Submission date Jun 11, 2015
Last update date Jul 03, 2019
Contact name Woonyoung Choi
Organization name Md Anderson Cancer center
Street address 1515 Holcombe
City Houston
State/province TX
ZIP/Postal code 77030
Country USA
 
Platforms (1)
GPL14951 Illumina HumanHT-12 WG-DASL V4.0 R2 expression beadchip
Samples (61)
GSM1709066 GSM1173968
GSM1709067 GSM1173969
GSM1709068 GSM1173970
Relations
BioProject PRJNA286784

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE69795_non-normalized.txt.gz 9.5 Mb (ftp)(http) TXT
Processed data included within Sample table

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap
External link. Please review our privacy policy.